NASDAQ
BRKR

Bruker Corporation

Medical Devices
Healthcare

Prices are adjusted according to historical splits.

Bruker Corporation Stock Price

Vitals

Today's Low:
$61.41
Today's High:
$62.35
Open Price:
$61.94
52W Low:
$48.3136
52W High:
$84.7797
Prev. Close:
$62.25
Volume:
892329

Company Statistics

Market Cap.:
$10.71 billion
Book Value:
8.042
Revenue TTM:
$2.62 billion
Operating Margin TTM:
18.34%
Gross Profit TTM:
$1.31 billion
Profit Margin:
11.89%
Return on Assets TTM:
8.22%
Return on Equity TTM:
27.91%

Company Profile

Bruker Corporation had its IPO on 2000-08-04 under the ticker symbol BRKR.

The company operates in the Healthcare sector and Medical Devices industry. Bruker Corporation has a staff strength of 8,525 employees.

Stock update

Shares of Bruker Corporation opened at $61.94 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $61.41 - $62.35, and closed at $61.76.

This is a -0.79% slip from the previous day's closing price.

A total volume of 892,329 shares were traded at the close of the day’s session.

In the last one week, shares of Bruker Corporation have slipped by -6.34%.

Bruker Corporation's Key Ratios

Bruker Corporation has a market cap of $10.71 billion, indicating a price to book ratio of 10.4214 and a price to sales ratio of 3.8071.

In the last 12-months Bruker Corporation’s revenue was $2.62 billion with a gross profit of $1.31 billion and an EBITDA of $573 million. The EBITDA ratio measures Bruker Corporation's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Bruker Corporation’s operating margin was 18.34% while its return on assets stood at 8.22% with a return of equity of 27.91%.

In Q1, Bruker Corporation’s quarterly earnings growth was a positive 27% while revenue growth was a positive 15.2%.

Bruker Corporation’s PE and PEG Ratio

Forward PE
26.1097
Trailing PE
34.7524
PEG
3.64

Its diluted EPS in the last 12-months stands at $2.1 per share while it has a forward price to earnings multiple of 26.1097 and a PEG multiple of 3.64. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Bruker Corporation’s profitability.

Bruker Corporation stock is trading at a EV to sales ratio of 4.1074 and a EV to EBITDA ratio of 19.6796. Its price to sales ratio in the trailing 12-months stood at 3.8071.

Bruker Corporation stock pays annual dividends of $0.2 per share, indicating a yield of 0.27% and a payout ratio of 8.03%.

Balance sheet and cash flow metrics

Total Assets
$3.76 billion
Total Liabilities
$1.05 billion
Operating Cash Flow
$-108200000.00
Capital Expenditure
$25 million
Dividend Payout Ratio
8.03%

Bruker Corporation ended 2024 with $3.76 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $3.76 billion while shareholder equity stood at $1.20 billion.

Bruker Corporation ended 2024 with $0 in deferred long-term liabilities, $1.05 billion in other current liabilities, 1700000.00 in common stock, $0 in retained earnings and $527.30 million in goodwill. Its cash balance stood at $597.90 million and cash and short-term investments were $597.90 million. The company’s total short-term debt was $120,100,000 while long-term debt stood at $1.11 billion.

Bruker Corporation’s total current assets stands at $2.14 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $471.70 million compared to accounts payable of $196.20 million and inventory worth $858.80 million.

In 2024, Bruker Corporation's operating cash flow was $-108200000.00 while its capital expenditure stood at $25 million.

Comparatively, Bruker Corporation paid $0.08 in dividends in 2024.

Other key metrics

Current Trading Price
$61.76
52-Week High
$84.7797
52-Week Low
$48.3136
Analyst Target Price
$88.11

Bruker Corporation stock is currently trading at $61.76 per share. It touched a 52-week high of $84.7797 and a 52-week low of $84.7797. Analysts tracking the stock have a 12-month average target price of $88.11.

Its 50-day moving average was $68.15 and 200-day moving average was $71.6 The short ratio stood at 3.05 indicating a short percent outstanding of 0%.

Around 3286% of the company’s stock are held by insiders while 7209% are held by institutions.

Frequently Asked Questions About Bruker Corporation

The stock symbol (also called stock or share ticker) of Bruker Corporation is BRKR

The IPO of Bruker Corporation took place on 2000-08-04

Similar Industry Stocks (Medical Devices)

Last Price
Chg
Chg%
$5.48
0.27
+5.18%
$0.69
0.03
+4.55%
$0.17
-0
-2.35%
$2349.7
-1.95
-0.08%
$45.38
0.05
+0.11%
$329.65
-5
-1.49%
$119.1
-2.65
-2.18%
$6.19
0
0%
$7.23
-1.99
-21.57%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Address

40 Manning Road, Billerica, MA, United States, 01821